1,4-Phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3644-3648

  Tanaka, Takuji ^a   Makita, Hiroki ^a   Kawabata, Kunihiro ^a   Mori, Hideki ^a   El Bayoumy, Karam ^b  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; GLUTATHIONE TRANSFERASE; ORGANOSELENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CANCER RISK; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; DRUG EFFICACY; ENZYME ACTIVITY; EPITHELIUM CELL; LABELING INDEX; NONHUMAN; PRIORITY JOURNAL; RAT; TONGUE CARCINOMA;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANTICARCINOGENIC AGENTS; BIOLOGICAL MARKERS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; DRUG SCREENING ASSAYS, ANTITUMOR; GLUTATHIONE TRANSFERASE; HYPERPLASIA; MALE; NAD(P)H DEHYDROGENASE (QUINONE); NEOPLASMS, EXPERIMENTAL; ORGANOSELENIUM COMPOUNDS; PAPILLOMA; POLYAMINES; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; TONGUE; TONGUE NEOPLASMS;

EID: 0030848525     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Meyskens, F. L., Jr. Biology and intervention of the premalignant process. Cancer Bull., 43: 475-480, 1991.
2. Boone, C. W., Kelloff, G. J., and Steele, V. Histopathology of the premalignant process. Cancer Bull., 1991: 481-484, 1991.
3. Tanaka, T. Chemoprevention of oral carcinogenesis. Eur. J. Cancer, 31B: 3-15, 1995.
4. Jovanoic, A., Schulten, E. A. J. M., Kostense, G. B., and van der Waal, I. Tobacco and alcohol related to the anatomical site of oral squamous cell carcinoma. J. Oral Pathol. Med., 22: 459-462, 1993.
5. Blot, W. J., McLaughlin, J. K., Winn, D. M., Austin, D. F., Greenberg, R. S., Preston-Martin, S., Bernstein, L., Schoenberg, J. B., Stemhargen, A., and Fraumeni, J. F. J. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res., 48: 3282-3287, 1988.
6. Mashberg, A., Boffetta, P., Winkleman, R., and Garfinkel, L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer (Phila.), 72: 1369-1375, 1993.
7. Licciardello, J. T. W., Spitz, M. R., and Hong, W. K. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus and lung. Int J. Radiat. Oncol. Biol. Phys., 17: 467-476, 1989.
8. Lippman, S. M., and Hong, W. K. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int. J. Radiat. Oncol. Biol. Phys., 17: 691-694, 1989.
9. Franco, E. L., Kowalski, L. P., and Kanda, J. L. Risk factors for second cancers of the upper respiratory and digestive system: a case-control study. J. Clin. Epidemiol., 44: 615-625, 1991.
10. Hays, G. L., Lippman, S. M. Flaitz, C. M., Brown, R. S., Pang, A., Devoll, R., and Hong, W. K. Co-carcinogenesis and field cancerization: oral lesions offer first signs. J. Am. Dental Assoc., 126: 47-51, 1995.
11. Slaughter, D. P., Southwick, H. W., and Smejkal, W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer (Phila.), 6: 963-968, 1953.
12. Sporn, M. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res., 36: 2699-2702, 1976.
13. Nauta, J. M., Roodenburg, L. N., Nikkels, P. G. J., Witjes, M. J. H., and Vermey, A. Comparison of epithelial dysplasia: the 4-NQO rat palate model and human oral mucosa. Int. J. Oral Maxillofac. Surg., 24: 53-58, 1995.
14. El-Bayoumy, K. The role of selenium in cancer prevention. In: V. T. J. DeVita, S. Hellman and S. A. Rosenberg (eds.), Cancer Principles and Practice of Oncology, pp. 1-15. Philadelphia: J. B. Lippincott Co., 1991.
15. Schrauzer, G. N., White, S. A., and Schneider, C. J. Cancer mortality correlation studies. III. Statistical associations with dietary selenium intakes. Bioinorg. Chem., 7: 23-31, 1977.
16. Willet, W. C., Morris, J. S., Pressel, S., Taylor, J. O., Polk, B. F., Stampher, M. J., Rosner, B., Schneider, K., and Hames, C. G. Prediagnostic serum selenium and risk of cancer. Lancet, ii: 130-134, 1983.
17. Goodwin, W. J. J., Lane, H. W., Bradford, K., Marshall, M. V., Griffin, A. C., Geopfert, H., and Jesse, R. H. Selenium and glutathione peroxidase levels in patients with epidemoid carcinoma of the oral cavity and oropharynx. Cancer (Phila.), 51: 110-115, 1983.
18. Rogers, M. A. M., Thomas, D. B., Davis, S., Weiss, N. S., Vaughan, T. L., and Nevissi, A. E. A case-control study of oral cancer and pre-diagnostic concentrations of selenium and zinc in nail tissue. Int. J. Cancer, 48: 182-188, 1991.
19. Krishnaswamy, K., Prasad, M. P. R., Krishna, T. P., and Pasricha, S. A case-control study of selenium in cancer. Indian J. Med. Res. Sect. B, 98: 124-128, 1993.
20. El-Bayoumy, K. Effects of organoselenium compounds on induction of mouse forestomach tumors by benzo(a)pyrene. Cancer Res., 45: 3631-3635, 1985.
21. Reddy, B. S., Sugie, S., Maruyama, H., El-Bayoumy, K., and Marra, P. Chemoprevention of colon carcinogenesis by dietary organoselenium, benzylselenocyanate, in F344 rats. Cancer Res., 47: 5901-5904, 1987.
22. Nayini, J., El-Bayoumy, K., Sugie, S., Cohen, L. A., and Reddy, B. S. Chemoprevention of experimental mammary carcinogenesis by the synthetic organoselenium compound, benzylselenocyanate, in rats. Carcinogenesis (Lond.), 10: 509-512, 1989.
23. El-Bayoumy, K., Upadhyaya, P., Chae, Y-H., Sohn, O-S., Rao, C. V., Fiala, E., and Reddy, B. S. Chemoprevention of cancer by organoselenium compounds. J. Cell. Biochem., 22 (Suppl.): 92-100, 1995.
24. Ip, C., El-Bayoumy, K., Upadhyaya, P., Ganther, H., Vadhanavikit, S., and Thompson, H. Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer Chemoprevention. Carcinogenesis (Lond.), 15: 187-192, 1994.
25. Reddy, B. S., Rivenson, A., Kulkarni, N., Upadhyaya, P., and El-Bayoumy, K. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Res., 52: 5635-5640, 1992.
26. Reddy, B. S., Rivenson, A., El-Bayoumy, K., Upadhyaya, P., Pittman, B., and Rao, C. V. Chemoprevention of colon cancer by organoselenium compounds and impact of high-or low-fat diets. J. Natl. Cancer Inst. (Bethesda), 89: 506-512, 1997.
27. El-Bayoumy, K., Chae, Y-H., Upadhyaya, P., Meschter, C., Cohen, L. A., and Reddy, B. S. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Cancer Res., 52: 2402-2407, 1992.
28. El-Bayoumy, K., Upadhyaya, P., Desai, D. H., Amin, S., and Hecht, S. S. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenicity in mouse lung by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Carcinogenesis (Lond.), 14: 1111-1113, 1993.
29. El-Bayoumy, K., Chae, Y-H., Upadhyaya, P., Meschter, C., Cohen, L. A., and Reddy, B. S. Selenium in chemoprevention of carcinogenesis. 11. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Res., 52: 2402-2407, 1992.
30. Bánóczy, J., and Csiba, A. Occurrence of epithelial dysplasia in oral leukoplakia. Oral Surg., 42: 766-774, 1976.
31. Kramer, I. R., Lucas, R. B., Pindborg, J. J., and Sobin, L. H. (WHO Collaborating Center for Oral Precancerous Lesions). Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg., 46: 518-539, 1978.
32. Koide, T., Sakai, S., Kawada, Y., Hara, A., and Sawada, H. Detection of polyamines by a new enzymatic differential assay. (7) Fundamental study on a new enzymatic differential assay of tissue polyamines (in Japanese). Acta Urol. Jpn., 36: 1103-1108, 1990.
33. Calhoun, K. H., Stanley, D., Stiernberg, C. M., and Ahmed, A. E. Vitamins A and E do protect against oral carcinoma. Arch. Otolaryngol. Head Neck Surg., 115: 484-488, 1989.
34. Benson, A. M., Batzinger, R. P., Ou, S-Y., Bueding, E., Cha, Y-N., and Talalay, P. Elevation of hepatic glutathione S-transferase activities and protection against metabolites of benzo(a)pyrene by dietary antioxidants. Cancer Res., 38: 4486-4495, 1978.
35. De Long, M. J., Prochaska, H. J., and Talalay, P. Tissue-specific induction patterns of cancer-protective enzymes in mice by tert-butyl-4-hydroxyanisole and related substituted phenols. Cancer Res., 45: 546-551, 1985.
36. Prochaska, H., and Fernandes, C. L. Elevation of serum phase II enzymes by anticarcinogenic enzyme inducers: markers for a chemoprotected state? Carcinogenesis (Lond.), 14: 2441-2445, 1993.
37. Benson, A. M., Hunkeler, M. J., and Talalay, P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA, 77: 5216-5220, 1980.
38. Habig, W. H., Pabst, M. J., and Jakoby, W. B. Glutathione S-transferases, J. Biol. Chem., 249: 7130-7139, 1974.
39. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 246-254, 1976.
40. Reddy, B. S., Upadhyaya, P., Simi, B., and Rao, C. V. Evaluation of organoselenium compounds for potential chemopreventive properties in colon carcinogenesis. Anticancer Res., 14: 2509-2514, 1994.
41. Reddy, B. S., Wynn, T. T., and El-Bayoumy, K. Evaluation of organoselenium compounds for potential chemopreventive properties in colon cancer. Anticancer Res., 16: 1123-1127, 1996.
42. Conaway, C. C., Upadhyaya, P., Meschter, C. L., Kurtzke, C., Marcus, L. A., and El-Bayoumy, K. Subchronic toxicity of benzyl selenocyanate and 1,4-phenylenebis(methylene)selenocyanate in F344 rats. Fundam. Appl. Toxicol., 19: 563-574, 1992.
43. Medina, D., Lane, H. W., and Tracey, C. M. Selenium and mouse mammary tumorigenesis: an investigation of possible mechanisms. Cancer Res., 43: 2460-2464, 1983.
44. Ronai, Z., Tillotson, J. K., Traganos, F., Darzynkiewicz, Z., Conaway, C. C., Upadhyaya, P., and El-Bayoumy, K. Effects of organic and inorganic selenium compounds on rat mammary tumor cells. Int. J. Cancer, 63: 428-434, 1995.
45. Prokopczyk, B., Cox, J. E., Upadhyaya, P., Amin, S., Desai, D., Hoffmann, D., and El-Bayoumy, K. Effects of dietary 1,4-phenylenebis(methylene)selenocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation in lung and liver of A/J mice and F344 rats. Carcinogenesis (Lond.), 17: 749-753, 1996.
46. Ip, C., Vadhanavikit, S., and Ganther, H. Cancer chemoprevention by aliphatic selenocyanates: effect of chain length on inhibition of mammary tumors and DMBA adducts. Carcinogenesis (Lond.), 16: 35-38, 1995.
47. Booth, D. R. A relationship found between intra-oral site of 4NQO reductase activity and chemical carcinogenesis. Cell Tissue Kinet., 23: 331-340, 1990.
48. Talalay, P. Chemical protection against cancer by induction of electrophilic detoxication (phase II) enzymes. In: V. E. Steel, G. D. Stoner, C. W. Boone, and G. J. Kelloff (eds.), Cellular and Molecular Targets for Chemoprevention, pp. 193-205. Boca Raton, FL: CRC Press, 1992.
49. Tillotson, J. K., Upadhyaya, P., and Ronai, Z. Inhibition of thymidine kinase in cultured mammary tumor cells by the chemopreventive organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Carcinogenesis (Lond.), 15: 607-610, 1994.
50. Foiles, P. G., Fujiki, H., Suganuma, M., Okabe, S., Yatsunami, J., Miglietta, L. M., Upadhyaya, P., El-Bayoumy, K., and Ronai, Z. Inhibition of PKC and PKA by chemopreventive organoselenium compounds. Int. J. Oncol., 7: 685-690, 1995.
51. Thompson, H. J., Wilson, A., Lu. J., Singh, M., Jiang, C., Upadhyaya, P., El-Bayoumy, K., and Ip, C. Comparison of the effects of an organic and inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis (Lond.), 15: 183-186, 1994.
52. Adler, V., Pincus, M. R., Posner, S., Upadhyaya, P., El-Bayoumy, K., and Ronai, Z. Effects of chemopreventive selenium compounds on Jun N-kinase activities. Carcinogenesis (Lond.), 17: 1849-1854, 1996.